BPC-157/TB-500 Blend 20mg

Important dilution note: Cloudiness after dilution is most commonly associated with non-pharmaceutical-grade dilution solution. Cloudy product concerns are not eligible for refund unless Pfizer pharmaceutical-grade dilution solution was used.

Vial Size: 3ml

Form: White Lyophilized Powder

Blend Composition: 10mg BPC-157 + 10mg TB-500 (Thymosin Beta-4) per vial

Molecular Formula: N/A — blend; see component data below

Molecular Weight: N/A — blend; see component data below

BPC-157 — CAS Number: 137525-51-0
BPC-157 — Chemical Name: Body Protection Compound-157
BPC-157 — Molecular Weight: 1,419.5 g/mol
BPC-157 — Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (15 AA)
BPC-157 — Receptor Activity: VEGF/EGF upregulation, NO synthesis modulation, angiogenic signaling in gastric mucosal and endothelial cell models

TB-500 — CAS Number: 77591-33-4
TB-500 — Chemical Name: Thymosin Beta-4
TB-500 — Molecular Weight: 4,921.5 g/mol
TB-500 — Sequence: Ac-SDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGES-OH (43 AA); LKKTETQ actin-binding motif at residues 17–23
TB-500 — Receptor Activity: G-actin sequestration, angiogenesis promotion via HIF-1α pathway, NF-κB-mediated inflammatory cytokine inhibition in preclinical models

Purity: ≥98% each component (HPLC) — see batch COA

Form: Lyophilized white to off-white powder

Storage Conditions: Store at −20°C, desiccated, protected from light. Stable 24 months lyophilized.

Solubility: Soluble in sterile water or 0.5% acetic acid at ≥1 mg/mL

Certificate of Analysis: Available for all batches.

For research and laboratory use only. Not for human or animal consumption. This product has not been evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any disease or condition. For use by qualified research professionals only.

Important dilution note: Cloudiness after dilution is most commonly associated with non-pharmaceutical-grade dilution solution. Cloudy product concerns are not eligible for refund unless Pfizer pharmaceutical-grade dilution solution was used.

Vial Size: 3ml

Form: White Lyophilized Powder

Blend Composition: 10mg BPC-157 + 10mg TB-500 (Thymosin Beta-4) per vial

Molecular Formula: N/A — blend; see component data below

Molecular Weight: N/A — blend; see component data below

BPC-157 — CAS Number: 137525-51-0
BPC-157 — Chemical Name: Body Protection Compound-157
BPC-157 — Molecular Weight: 1,419.5 g/mol
BPC-157 — Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (15 AA)
BPC-157 — Receptor Activity: VEGF/EGF upregulation, NO synthesis modulation, angiogenic signaling in gastric mucosal and endothelial cell models

TB-500 — CAS Number: 77591-33-4
TB-500 — Chemical Name: Thymosin Beta-4
TB-500 — Molecular Weight: 4,921.5 g/mol
TB-500 — Sequence: Ac-SDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGES-OH (43 AA); LKKTETQ actin-binding motif at residues 17–23
TB-500 — Receptor Activity: G-actin sequestration, angiogenesis promotion via HIF-1α pathway, NF-κB-mediated inflammatory cytokine inhibition in preclinical models

Purity: ≥98% each component (HPLC) — see batch COA

Form: Lyophilized white to off-white powder

Storage Conditions: Store at −20°C, desiccated, protected from light. Stable 24 months lyophilized.

Solubility: Soluble in sterile water or 0.5% acetic acid at ≥1 mg/mL

Certificate of Analysis: Available for all batches.

For research and laboratory use only. Not for human or animal consumption. This product has not been evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any disease or condition. For use by qualified research professionals only.